-
3D Systems Reports Third Quarter 2022 Financial Results
Source: Nasdaq GlobeNewswire / 08 Nov 2022 15:15:01 America/Chicago
ROCK HILL, S.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the third quarter ended September 30, 2022.
Third Quarter Highlights
- Revenue of $132.3 million decreased (15.3)% compared to Q3 2021; Q3 non-GAAP revenue excluding divestitures and on a constant currency basis(1) increased 2.7%, reflecting solid demand in both the Industrial and Healthcare segments, despite supply chain and macroeconomic challenges and lower sales to certain dental market customers
- Net loss of $(37.4) million, diluted loss per share of $(0.30), and diluted non-GAAP loss per share(1) of $(0.05)
- Adjusted EBITDA(1) of $(0.3) million reflects inflationary impacts on input costs and continued investments in growth areas of our business and product portfolio
- Cash & short-term investments of $609.4 million position the company for future growth investments.
- Fiscal year 2022 outlook updated to tighten revenue range and to improve the outlook for non-GAAP operating expenses
Three Months Ended
September 30, 2022Nine Months Ended
September 30, 2022Revenue Growth Rates (%) as reported (15.3) % (12.8) % Non-GAAP Revenue Growth Rates (%) excluding divestitures (3.2) % 3.1 % Non-GAAP Revenue Growth Rates (%) excluding divestitures and FX effects 2.7 % 7.6 % Three Months Ended
September 30,Nine Months Ended
September 30,(in millions, except per share data) 2022 2021 2022 2021 Revenue $ 132.3 $ 156.1 $ 405.3 $ 464.8 Operating loss $ (33.7 ) $ (17.2 ) $ (89.0 ) $ (29.2 ) Net (loss) income attributable to 3D Systems Corporation $ (37.4 ) $ 292.7 $ (97.2 ) $ 328.3 Net (loss) income per share - diluted $ (0.30 ) $ 2.34 $ (0.77 ) $ 2.63 Three Months Ended
September 30,Nine Months Ended
September 30,(in millions, except per share data) 2022 2021 2022 2021 Non-GAAP measures for year-over-year comparisons (excluding divestitures)(1) Non-GAAP Revenue $ 132.3 $ 136.7 $ 405.3 $ 393.1 Non-GAAP operating (loss) income $ (5.5 ) $ 6.0 $ (17.0 ) $ 21.4 Non-GAAP net (loss) income $ (6.3 ) $ 6.5 $ (21.9 ) $ 30.0 Non-GAAP (loss) income per share - diluted $ (0.05 ) $ 0.05 $ (0.18 ) $ 0.24 Adjusted EBITDA $ (0.3 ) $ 11.6 $ (1.0 ) $ 38.4 (1) See “Presentation of Information in this Press Release” below for a description and the attached schedules in the Appendix for reconciliations of non-GAAP measures to the most closely comparable GAAP measure.
Summary Comments on Results
Commenting on the results, President and CEO Dr. Jeffrey Graves said, “Our third quarter results were consistent with our recent expectations. We are seeing steady demand for our industry-leading suite of additive manufacturing solutions in core end markets such as energy, commercial space, precision micro-castings, and medical devices. However, as we had expected, the difficult global macroeconomic and geopolitical environment has put pressure on consumer discretionary spending, which led to significantly lower sales to key dental market customers during the quarter.”
Dr. Graves also noted, “Regarding our broader business, recent actions we have taken to control operating costs and to streamline our manufacturing and inventory management processes had a positive impact on the company’s profitability metrics during the third quarter. These actions are allowing us to better navigate ongoing supply chain pressures and more efficiently deliver additive manufacturing solutions that solve our customers’ most challenging production needs.”
“Over the last two and a half years, our entire team of talented employees has worked very hard to re-make 3D Systems into a provider of end-to-end additive solutions focused on high-growth applications for industrial and healthcare markets. With this transformation largely complete, our priorities are on operational execution and prudent investments in our broad product line of 3D printing technologies and software applications. In doing so, we are focusing on profitability and cash performance, while laying the foundation for the company to advance in exciting new directions to drive value for our customers and shareholders. An important milestone in this regard was our announcement during the third quarter that 3D Systems has formed a new internal biotech company called Systemic Bio that will apply advanced additive manufacturing techniques to accelerate drug discovery and development.”
Dr. Graves summarized, “Although the challenging macro environment has led to slower growth in certain key end-markets such as dental, I am confident that the long-term fundamentals remain very positive for additive manufacturing, in general, and for 3D Systems in particular. Our focus on operational execution to capitalize on our past investments remains our highest priority, while our strong balance sheet positions us well to continue investing in high margin, high growth areas of our businesses. With new opportunities for large-scale adoption of additive manufacturing opening before us, and entirely new markets being created in bioprinting, we believe we are very well positioned to deliver on our commitment to become a $1 billion revenue company in five years.”
Summary of Third Quarter Results
Revenue for the third quarter of 2022 decreased (15.3)% to $132.3 million, primarily due to divestitures of non-core businesses during 2021. Non-GAAP revenue excluding divestitures and on a constant currency basis grew 2.7% over the same period last year. The growth of non-GAAP revenue excluding divestitures and on a constant currency basis reflects continued solid product and service demand across both business segments, offset by lower sales to select dental customers due to macroeconomic factors that are negatively impacting the market for elective dental procedures.
Industrial revenue decreased (14.6)% to $68.1 million compared to the same period last year, however, non-GAAP revenue excluding divestitures and on a constant currency basis increased 9.0% year-over-year. Healthcare revenue decreased (16.0)% to $64.2 million, compared to the same period last year, and non-GAAP revenue excluding divestitures and on a constant currency basis decreased (3.5)% year-over-year.
Gross profit margin in the third quarter of 2022 was 39.8% compared to 41.2% in the same period last year. Gross profit margin decreased primarily due to input cost inflation, divestitures, and unfavorable product mix.
Operating expenses increased 6.0% to $86.4 million in the third quarter of 2022, compared to the same period a year ago. The higher operating expenses reflect spending in targeted areas to support future growth, including expenses from acquired businesses, research and development, and investments in corporate infrastructure, as well as a $9.0 million increase in legal and other settlement costs, partially offset by the absence of expenses from divested businesses. Non-GAAP operating expenses increased from $49.3 million in Q3 2021 to $58.3 million in Q3 2022. The higher non-GAAP operating expenses reflect spending in targeted areas to support future growth.
Revising FY 2022 Guidance
3D Systems is updating its FY 2022 guidance to significantly tighten the revenue range and to improve the outlook for reduced non-GAAP operating expenses. These changes to FY 2022 guidance are based on improved visibility into likely revenue performance during the fourth quarter of 2022 as well the impact of cost-efficiency actions.
FY 2022 Guidance as of: August 9, 2022 November 9, 2022 Revenue: $530 - $570 million $535 - $545 million Non-GAAP Gross Profit Margin: 39% - 41% 39% - 41% Non-GAAP Operating Expenses: $245 - $250 million $240 - $245 million Our revised FY 2022 guidance assumes no significant additional changes in the macroeconomic environment that could negatively impact our business demand or disrupt our supply chain, such as a resurgence of business and/or travel restrictions related to COVID-19, geopolitical events, recession, or foreign exchange rate fluctuations.
Financial Liquidity
As of September 30, 2022, the company had cash and short-term investments on hand of $609.4 million. Cash and short-term investments have decreased $180.3 million since December 31, 2021, driven primarily by $84.7 million paid for acquisitions and equity investments, cash used in operations of $52.4 million, capital expenditures of $17.1 million, and other cash used for financing activities of $13.0 million.
Q3 2022 Conference Call and Webcast
3D Systems will host a conference call and simultaneous webcast to discuss these results tomorrow morning, which may be accessed as follows:
Date: Wednesday, November 9, 2022
Time: 8:30 a.m. Eastern Time
Listen via webcast: www.3dsystems.com/investor
Participate via telephone: 201-689-8345A replay of the webcast will be available approximately two hours after the live presentation at www.3dsystems.com/investor.
Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward looking statements can be identified by terms such as “believes,” “belief,” “expects,” “may,” “will,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations, may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business, and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as, a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.
Presentation of Information in this Press Release
3D Systems reports its financial results in accordance with GAAP. Management also reviews and reports certain non-GAAP measures, including: non-GAAP revenue excluding divestitures and on a constant currency basis (sometimes referred to as excluding divestitures and FX effects), non-GAAP gross profit, non-GAAP gross profit margin, non-GAAP operating expenses, non-GAAP operating (loss)/income, non-GAAP interest and other income/(expense), net, non-GAAP net income (loss), non-GAAP basic and diluted income (loss) per share, adjusted EBITDA, and adjusted EBITDA margin. These non-GAAP measures exclude certain special items that management does not view as part of 3D Systems’ core underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Management believes that the non-GAAP measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of period-over-period results. Additionally, management uses the non-GAAP measures for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. 3D Systems’ non-GAAP measures are not calculated in accordance with or as required by GAAP and may not be calculated the same as similarly titled measures used by other companies. These non-GAAP measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
To calculate the non-GAAP measures, 3D Systems excludes the impact of the following items:
- amortization of intangible assets, a non-cash expense, as 3D Systems’ intangible assets were primarily acquired in connection with business combinations;
- costs incurred in connection with acquisitions and divestitures, such as legal, consulting and advisory fees;
- stock-based compensation expenses, a non-cash expense;
- restructuring charges (cost optimization plans), impairment charges, including goodwill and divestiture gains or losses;
- certain legal costs and other settlements;
- certain compensation expense related to the 2021 Volumetric acquisition; and
- revenue and costs from 2021 divested businesses are excluded from 2021 reported results so the results are comparable to the current period.
Amortization of intangibles, acquisition and divestiture related costs are excluded from non-GAAP measures as the timing and magnitude of business combination transactions are not predictable, can vary significantly from period to period and the purchase price allocated to amortizable intangible assets and the related amortization period are unique to each acquisition. Amortization of intangible assets will recur in future periods until such intangible assets have been fully amortized. While intangible assets contribute to the company’s revenue generation, the amortization of intangible assets does not directly relate to the sale of the company’s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the company’s acquisition activity. Accordingly, the company believes excluding the amortization of intangible assets enhances the company’s and investors’ ability to compare the company’s past financial performance with its current performance and to analyze underlying business performance and trends. Although stock-based compensation is a key incentive offered to certain of our employees, we continue to evaluate our business performance excluding stock-based compensation; therefore, it is excluded from non-GAAP measures. Stock-based compensation expenses will recur in future periods. Restructuring charges (cost optimization plans), impairment charges, including goodwill and divestiture gains or losses, are excluded from non-GAAP measures as the frequency and magnitude of these activities may vary widely from period to period. Additionally, impairment charges, including goodwill, are non-cash. Certain legal costs and other settlement expenses are excluded as the timing and magnitude are not predictable and can vary from period to period distorting underlying business trends and results. Additionally, these amounts are not included when allocating resources and evaluating results relative to employee compensation targets. Furthermore, 3D Systems excludes contingent consideration recorded as compensation expense related to the 2021 Volumetric acquisition from non-GAAP measures as management evaluates financial performance excluding this expense, which is viewed by management as similar to acquisition consideration.
The matters discussed above are tax effected, as applicable, in calculating non-GAAP net income and basic and diluted earnings per share.
Non-GAAP revenue excluding divestitures and on a constant currency basis, as used in this earnings release, means reported revenue less revenue from businesses divested in 2021 and adjusted for foreign exchange changes for the quarter and nine months ended September 30, 2021, estimated using the same exchange rates as applied for the respective period in 2022. Non-GAAP revenue excluding divestitures and on a constant currency basis is used to assist management in the analysis of the company’s net revenue trends.
Adjusted EBITDA, defined as net income, plus income tax (provision)/benefit, interest and other income/(expense), net, stock-based compensation expense, amortization of intangibles, depreciation expense and other non-recurring and/or non-cash items all as described above (excluding the impact of divestitures in 2021), is used by management to evaluate performance and helps measure financial performance period-over-period.
A reconciliation of GAAP to non-GAAP financial measures is provided in the accompanying schedules in the Appendix.
3D Systems does not provide forward-looking guidance for certain measures on a GAAP basis. The company is unable to provide a quantitative reconciliation of forward-looking non-GAAP gross profit margins and non-GAAP operating expenses to the most directly comparable forward-looking GAAP measures without unreasonable effort because certain items, including legal, acquisition expenses, stock-compensation expense, intangible amortization expense, restructuring expenses, and goodwill impairment, are difficult to predict and estimate. These items are inherently uncertain and depend on various factors, many of which are beyond the company’s control, and as such, any associated estimate and its impact on GAAP performance could vary materially.
About 3D Systems
More than 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading Additive Manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in Healthcare and Industrial markets such as Medical and Dental, Aerospace & Defense, Automotive and Durable Goods. More information on the company is available at www.3dsystems.com
Investor Contact: investor.relations@3dsystems.com
Media Contact: press@3dsystems.comTables Follow:
3D Systems Corporation Unaudited Condensed Consolidated Balance Sheets September 30, 2022 and December 31, 2021 (Unaudited) (In thousands, except par value) September 30,
2022December 31,
2021ASSETS Current assets: Cash and cash equivalents $ 341,297 $ 789,657 Short-term investments 268,097 — Accounts receivable, net of reserves — $3,049 and $2,445 100,310 106,540 Inventories 125,962 92,887 Prepaid expenses and other current assets 29,599 42,653 Total current assets 865,265 1,031,737 Property and equipment, net 55,942 57,257 Intangible assets, net 82,538 45,835 Goodwill 357,545 345,588 Right of use assets 41,810 46,356 Deferred income tax asset 4,337 5,054 Other assets 23,933 17,272 Total assets $ 1,431,370 $ 1,549,099 LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND EQUITY Current liabilities: Current lease liabilities $ 8,205 $ 8,344 Accounts payable 53,419 57,366 Accrued and other liabilities 56,016 76,994 Customer deposits 7,089 7,281 Deferred revenue 27,644 28,027 Total current liabilities 152,373 178,012 Long-term debt, net of deferred financing costs 448,852 446,859 Long-term lease liabilities 42,011 47,420 Deferred income tax liability 8,577 2,173 Other liabilities 43,647 32,254 Total liabilities 695,460 706,718 Commitments and contingencies (Note 14) Redeemable noncontrolling interest 1,654 — Stockholders’ equity: Common stock, $0.001 par value, authorized 220,000 shares; shares issued and outstanding 130,419 and 128,375 130 128 Additional paid-in capital 1,533,340 1,501,210 Accumulated deficit (718,410 ) (621,251 ) Accumulated other comprehensive loss (80,804 ) (37,706 ) Total stockholders’ equity 734,256 842,381 Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 1,431,370 $ 1,549,099 3D Systems Corporation Unaudited Condensed Consolidated Statements of Operations Three and Nine Months Ended September 30, 2022 and 2021 (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (in thousands, except per share amounts) 2022 2021 2022 2021 Revenue: Products $ 96,337 $ 108,884 $ 300,662 $ 311,170 Services 35,916 47,212 104,637 153,599 Total revenue 132,253 156,096 405,299 464,769 Cost of sales: Products 58,042 64,252 181,845 180,251 Services 21,541 27,529 63,851 86,958 Total cost of sales 79,583 91,781 245,696 267,209 Gross profit 52,670 64,315 159,603 197,560 Operating expenses: Selling, general and administrative 65,579 65,737 185,398 176,800 Research and development 20,796 15,786 63,180 49,987 Total operating expenses 86,375 81,523 248,578 226,787 Loss from operations (33,705 ) (17,208 ) (88,975 ) (29,227 ) Interest and other income (expense), net (3,502 ) 315,859 (5,456 ) 354,396 (Loss) income before income taxes (37,207 ) 298,651 (94,431 ) 325,169 (Provision) benefit for income taxes (338 ) (5,995 ) (2,911 ) 3,083 Net (loss) income before redeemable non-controlling interest (37,545 ) 292,656 (97,342 ) 328,252 Less: net (loss) attributable to redeemable noncontrolling interests (147 ) — (184 ) — Net (loss) income attributable to 3D Systems Corporation $ (37,398 ) $ 292,656 $ (97,158 ) $ 328,252 Net (loss) income per common share: Basic $ (0.30 ) $ 2.39 $ (0.77 ) $ 2.69 Diluted $ (0.30 ) $ 2.34 $ (0.77 ) $ 2.63 Weighted average shares outstanding: Basic 127,991 122,663 127,478 122,178 Diluted 127,991 125,289 127,478 124,839 3D Systems Corporation Unaudited Condensed Consolidated Statements of Cash Flows Nine Months Ended September 30, 2022 and 2021 (Unaudited) Nine Months Ended September 30, (in thousands) 2022 2021 Cash flows from operating activities: Net (loss) income $ (97,342 ) $ 328,252 Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Depreciation, amortization and accretion of debt discount 28,264 26,292 Stock-based compensation 31,508 43,991 Loss on short-term investments 2,609 — Provision for inventory obsolescence and revaluation 646 1,100 Loss on hedge accounting de-designation and termination — 721 Provision for bad debts 329 620 (Gain) on the disposition of businesses, property, equipment and other assets (365 ) (351,981 ) Provision (benefit) for deferred income taxes and reserve adjustments 1,666 (9,380 ) Asset impairment 2,359 — Changes in operating accounts: Accounts receivable (1,513 ) (2,151 ) Inventories (30,342 ) 7,095 Prepaid expenses and other current assets 2,562 5,338 Accounts payable (1,666 ) 15,517 Deferred revenue and customer deposits (3,468 ) 5,401 Accrued and other liabilities 12,387 (9,859 ) All other operating activities (83 ) 1,696 Net cash (used in) provided by operating activities (52,449 ) 62,652 Cash flows from investing activities: Purchases of property and equipment (17,055 ) (14,814 ) Purchases of short-term investments (384,406 ) — Sales and maturities of short-term investments 112,050 — Proceeds from sale of assets and businesses, net of cash sold — 427,664 Acquisitions and other investments, net of cash acquired (84,705 ) (10,936 ) Other investing activities — (2,273 ) Net cash (used in) provided by investing activities (374,116 ) 399,641 Cash flows from financing activities: Repayment of borrowings/long-term debt — (21,392 ) Debt issuance cost — — Purchase of noncontrolling interest (2,300 ) (4,000 ) Taxes paid related to net-shares settlement of equity awards (10,195 ) (10,386 ) Other financing activities (486 ) (424 ) Net cash used in financing activities (12,981 ) (36,202 ) Effect of exchange rate changes on cash, cash equivalents and restricted cash (7,911 ) (7,737 ) Net (decrease) increase in cash, cash equivalents and restricted cash (447,457 ) 418,354 Cash, cash equivalents and restricted cash at the beginning of the period(a) 789,970 84,711 Cash, cash equivalents and restricted cash at the end of the period(a) $ 342,513 $ 503,065 - The amounts for cash and cash equivalents shown above include restricted cash of $1,216 and $313 as of September 30, 2022, and 2021, respectively, and $313, $540, as of December 31, 2021 and 2020, respectively, which were included in prepaid expenses and other assets net on the condensed consolidated balance sheet.
Appendix 3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures Three Months Ended September 30, 2022 and 2021 Table 1 (in millions, except per share data) Three Months Ended September 30, 2022,(1) GAAP Amortization, stock-based compensation & other Legal, acquisition and divestiture -related(2) Cost optimization plan(2) Impairment of cost-method investments Non-GAAP Revenue $ 132.3 — — $ — $ — $ 132.3 Gross Profit 52.7 0.2 — — — 52.8 Gross Profit Margin 39.8 % 39.9 % Operating expenses 86.4 (17.6 ) (10.2 ) (0.3 ) — 58.3 Operating (loss) income (33.7 ) 17.8 10.2 0.3 — (5.5 ) Interest and other income (expense), net (3.5 ) — — — 2.9 (0.6 ) Net (loss) income attributable to 3D Systems Corporation (37.4 ) 17.8 10.2 0.3 2.9 (6.3 ) Basic and diluted net (loss) income per share $ (0.30 ) $ 0.14 $ 0.08 $ — $ 0.02 $ (0.05 ) Basic and diluted shares outstanding 128.0 128.0 (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
(2) Included are $9.7 million of estimated costs for legal and other settlements(in millions, except per share data) Three Months Ended September 30, 2021,(1) GAAP Amortization, stock-based compensation & other Legal, acquisition and divestiture -related Cost optimization plan and other Divestitures(2) Non-GAAP Revenue $ 156.1 — — — (19.4 ) $ 136.7 Gross Profit 64.3 — — 0.4 (9.4 ) 55.3 Gross Profit Margin 41.2 % 40.5 % Operating expenses 81.5 (16.1 ) (11.4 ) — (4.7 ) 49.3 Operating (loss) income (17.2 ) 16.1 11.4 0.4 (4.7 ) 6.0 Interest and other income (expense), net 315.9 — (315.5 ) — 0.9 1.3 Net (loss) income 292.7 16.1 (299.1 ) 0.4 (3.6 ) 6.5 Basic net (loss) income per share 2.39 0.13 (2.44 ) — (0.03 ) 0.05 Diluted net (loss) income per share $ 2.34 $ 0.13 $ (2.39 ) $ — $ (0.03 ) $ 0.05 Basic shares outstanding 122.7 122.7 Diluted shares outstanding 125.3 125.3 (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
(2) Simbionix and ODM businesses were sold in the third quarter of 2021Appendix 3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures (Continued) Nine Months Ended September 30, 2022 and 2021 Table 2 (in millions, except per share data) Nine Months Ended September 30, 2022 GAAP Amortization, stock-based compensation & other Legal, acquisition and divestiture - related(2) Cost optimization plan Impairment of cost-method investments Non-GAAP Revenue $ 405.3 $ — $ — $ — $ — $ 405.3 Gross Profit 159.6 0.4 — — — 160.0 Gross Profit Margin 39.4 % 39.5 % Operating expenses 248.6 (47.3 ) (22.7 ) (1.5 ) — 177.0 Operating (loss) income (89.0 ) 47.7 22.7 1.5 — (17.0 ) Interest and other income (expense), net (5.5 ) — 0.4 — 2.9 (2.2 ) Net (loss) income attributable to 3D Systems Corporation (97.2 ) 47.7 23.1 1.5 2.9 (21.9 ) Basic and diluted net (loss) income per share $ (0.77 ) $ 0.37 $ 0.18 $ 0.01 $ 0.02 $ (0.18 ) Basic and diluted shares outstanding 127.5 127.5 (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
(2) Included are $18.1 million of estimated costs for legal and other settlements(in millions, except per share data)(1) Nine Months Ended September 30, 2021 GAAP Amortization, stock-based compensation & other Legal, acquisition and divestiture-related(2) Cost optimization plan and other Divestitures(3) Non-GAAP Revenue $ 464.8 $ — $ — $ — $ (71.7 ) $ 393.1 Gross Profit 197.6 0.3 — — (33.5 ) 164.4 Gross Profit Margin 42.5 % 41.8 % Operating expenses 226.8 (51.2 ) (13.6 ) (1.6 ) (17.3 ) 143.2 Operating (loss) income (29.2 ) 51.5 13.6 1.6 (16.2 ) 21.4 Interest and other income (expense), net 354.4 — (354.9 ) — 1.1 0.5 Net income (loss) 328.3 51.5 (336.2 ) 1.6 (15.1 ) 30.0 Basic net income (loss) per share 2.69 0.42 (2.75 ) 0.01 (0.12 ) 0.25 Diluted net income (loss) per share $ 2.63 $ 0.41 $ (2.69 ) $ 0.01 $ (0.12 ) $ 0.24 Basic shares outstanding 122.2 122.2 Diluted shares outstanding 124.8 124.8 (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
(2)Includes gain from divestiture of Cimatron in interest and other income (expense), net
(3) Simbionix and ODM businesses were sold in the third quarter of 2021Appendix 3D Systems Corporation Non-GAAP Operating Income (excluding 2021 divestitures) to Adjusted EBITDA Reconciliation Three and Nine Months Ended September 30, Table 3 Three Months Ended September 30,(1) Nine Months Ended September 30,(1) (in millions) 2022 2021 2022 2021 Revenue - 2021 excludes revenue from divestitures $ 132.3 $ 136.7 $ 405.3 $ 393.1 Non-GAAP Operating (loss) income (5.5 ) 6.0 (17.0 ) 21.4 Depreciation 5.2 5.6 16.0 17.0 Adjusted EBITDA $ (0.3 ) $ 11.6 $ (1.0 ) $ 38.4 Adjusted EBITDA Margin (0.2 )% 8.4 % (0.2 )% 9.8 % (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
Appendix 3D Systems Corporation Reconciliation of Revenue to Non-GAAP Revenue(1) Three and Nine Months Ended September 30, (in Millions, unaudited) Table 4 Three Months Ended September 30, 2022 Three Month Ended September 30, 2021 % Change Constant Currency(2) FX Effect(3) B(W)% Revenue, as reported Healthcare $ 64.2 $ 76.4 (16.0) % Industrial 68.1 79.7 (14.6) % Total Revenue, as reported $ 132.3 $ 156.1 (15.2) % Revenue From Divestitures: Healthcare $ — $ 7.7 Industrial — 11.7 Total Revenue $ — $ 19.4 Total Revenue (Excl. Divest. and FX Effect): Healthcare $ 64.2 $ 68.7 (6.6) % $ (2.1) (3.5) % Industrial 68.1 68.0 0.1 % (6.0) 9.0 % Total Revenue (Excl. Divest. and FX Effect): $ 132.3 $ 136.7 (3.2) % $ (8.1) 2.7 % Nine Months Ended
September 30, 2022Nine Months Ended
September 30, 2021% Change Constant Currency(2) FX Effect(3) B(W)% Revenue, as reported Healthcare $ 200.3 $ 231.7 (13.6) % Industrial 205.0 233.1 (12.1) % Total Revenue, as reported $ 405.3 $ 464.8 (12.8) % Revenue From Divestitures: Healthcare $ — $ 31.8 Industrial 39.9 Total Revenue $ — $ 71.7 Total Revenue (Excl. Divest. and FX Effect): Healthcare $ 200.3 $ 199.9 0.2 % $ (4.1 ) 2.2 % Industrial 205.0 193.2 6.1 % (13.4 ) 13.1 % Total Revenue (Excl. Divest. and FX Effect): $ 405.3 $ 393.1 3.1 % $ (17.5 ) 7.6 % (1)Amounts in table may not foot due to rounding and percent changes have been calculated based upon rounded amounts
(2) To assist in the analysis of the company’s revenue trends, the company estimated the impact of foreign exchange on year over year revenue growth by recasting revenue, excluding divestitures, for the three and nine months ended September 30, 2021 by applying the foreign exchange rates used to translate 2021 non-US functional currency revenue to 2022 non-US functional currency revenue.
(3) FX effect is the estimated impact on “as reported” net revenue due to changes in foreign currency exchange rates
